Sunder Biomedical Tech. Co., Ltd.
Sunder Biomedical Tech. Co., Ltd. engages in the manufacture and sale of medical devices. It offers endoscopy vision set, suction irrigation set, smoke filter, endo bag, blood line set for hemodialysis, A.V. fistula needle, I.V. administration, volume control I.V. administration, extension tube. surgical tubing set, PVC compounds for medical application, transducer protector, melt blown nonwoven … Read more
Sunder Biomedical Tech. Co., Ltd. (4115) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.046x
Based on the latest financial reports, Sunder Biomedical Tech. Co., Ltd. (4115) has a cash flow conversion efficiency ratio of 0.046x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$33.84 Million) by net assets (NT$730.10 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Sunder Biomedical Tech. Co., Ltd. - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Sunder Biomedical Tech. Co., Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Sunder Biomedical Tech. Co., Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sunder Biomedical Tech. Co., Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Asia Pacific Investment JSC
VN:API
|
N/A |
|
American Noble Gas Inc.
OTCQB:AMNI
|
0.045x |
|
Linklogis Inc. Class B
F:0NY
|
N/A |
|
Traction Uranium Corp.
OTCQB:TRCTD
|
-0.353x |
|
BC IRON (BC3.SG)
STU:BC3
|
N/A |
|
Bela Automotive Limited
KAR:BELA
|
N/A |
|
Egyptian Real Estate Group Bearer Shares
EGX:AREHA
|
N/A |
|
CMDKF
PINK:CMDKF
|
N/A |
Annual Cash Flow Conversion Efficiency for Sunder Biomedical Tech. Co., Ltd. (2020–2024)
The table below shows the annual cash flow conversion efficiency of Sunder Biomedical Tech. Co., Ltd. from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$777.43 Million | NT$108.13 Million | 0.139x | +115.90% |
| 2023-12-31 | NT$735.89 Million | NT$47.41 Million | 0.064x | -51.23% |
| 2022-12-31 | NT$790.45 Million | NT$104.42 Million | 0.132x | -39.91% |
| 2021-12-31 | NT$809.01 Million | NT$177.86 Million | 0.220x | +58.56% |
| 2020-12-31 | NT$755.45 Million | NT$104.75 Million | 0.139x | -- |